We are live on ! Find out more
TCA

Transcend Capital Advisors Portfolio holdings

AUM $1.25B
1-Year Est. Return 17.69%
This Fund
S&P 500
This Quarter Est. Return
+6.44%
1 Year Est. Return
+17.69%
3 Year Est. Return
+61.21%
5 Year Est. Return
+70.44%
10 Year Est. Return
AUM
$1.13B
AUM Growth
+$16.7M
Cap. Flow
+$30.5M
Cap. Flow %
2.69%
Top 10 Hldgs %
27.68%
Holding
528
New
41
Increased
251
Reduced
124
Closed
40

Sector Composition

Rank Sector Weight
1 Technology 19.58%
2 Financials 18.17%
3 Healthcare 7.94%
4 Consumer Discretionary 4.92%
5 Communication Services 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVY icon
151
iShares Select Dividend ETF
DVY
$24.1B
$1.8M 0.16%
14,676
+7
+0% +$834
ESGE icon
152
iShares ESG Aware MSCI EM ETF
ESGE
$6.41B
$1.77M 0.16%
44,656
-1,972
-4% -$81.3K
FALN icon
153
iShares Fallen Angels USD Bond ETF
FALN
$1.63B
$1.75M 0.15%
58,332
-2,027
-3% -$60.6K
CL icon
154
Colgate-Palmolive
CL
$74.2B
$1.74M 0.15%
20,419
-29
-0.1% -$2.27K
FXI icon
155
iShares China Large-Cap ETF
FXI
$4.27B
$1.74M 0.15%
47,470
+11,528
+32% +$452K
APD icon
156
Air Products & Chemicals
APD
$65.2B
$1.72M 0.15%
5,648
+266
+5% +$78.1K
XBI icon
157
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$1.7M 0.15%
15,207
+10,262
+208% +$1.24M
FSK icon
158
FS KKR Capital
FSK
$3.08B
$1.69M 0.15%
80,589
+2,513
+3% +$54.3K
CWI icon
159
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.73B
$1.69M 0.15%
57,500
+800
+1% +$23.6K
VO icon
160
Vanguard Mid-Cap ETF
VO
$107B
$1.65M 0.15%
25,872
+6,284
+32% +$394K
ETN icon
161
Eaton
ETN
$150B
$1.64M 0.15%
9,500
-368
-4% -$61K
FOLD
162
DELISTED
Amicus Therapeutics
FOLD
$1.64M 0.14%
142,064
-800
-0.6% -$8.92K
FCX icon
163
Freeport-McMoran
FCX
$88.6B
$1.64M 0.14%
39,222
-2,063
-5% -$78.4K
STX icon
164
Seagate
STX
$169B
$1.6M 0.14%
14,201
+523
+4% +$50.8K
IBB icon
165
iShares Biotechnology ETF
IBB
$9.55B
$1.59M 0.14%
10,435
+36
+0.3% +$5.57K
USMV icon
166
iShares MSCI USA Min Vol Factor ETF
USMV
$23.7B
$1.58M 0.14%
19,545
-158
-0.8% -$12.2K
IJR icon
167
iShares Core S&P Small-Cap ETF
IJR
$110B
$1.58M 0.14%
13,793
+644
+5% +$73.4K
TIP icon
168
iShares TIPS Bond ETF
TIP
$14.5B
$1.56M 0.14%
12,087
+356
+3% +$45.9K
EMXC icon
169
iShares MSCI Emerging Markets ex China ETF
EMXC
$22.8B
$1.54M 0.14%
25,371
+674
+3% +$41K
IEI icon
170
iShares 3-7 Year Treasury Bond ETF
IEI
$18.1B
$1.52M 0.13%
11,814
+473
+4% +$61.1K
YUM icon
171
Yum! Brands
YUM
$41.4B
$1.51M 0.13%
10,894
IYG icon
172
iShares US Financial Services ETF
IYG
$2.18B
$1.5M 0.13%
23,235
-1,083
-4% -$70.6K
BABA icon
173
Alibaba
BABA
$276B
$1.49M 0.13%
12,501
-9,940
-44% -$1.45M
BP icon
174
BP
BP
$107B
$1.48M 0.13%
55,704
+14,943
+37% +$414K
MO icon
175
Altria Group
MO
$125B
$1.48M 0.13%
31,239
+9,707
+45% +$445K

Similar funds

Transcend Capital Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Transcend Capital Advisors held 528 positions worth $1.13B, up 1.5% from $1.12B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Transcend Capital Advisors's Q4 2021 filing shows 41 new, 251 increased, 124 reduced and 40 closed positions. Its largest new stake was ITT: 21,295 shares worth $2.18M. The largest sale was Intercontinental Exchange, an estimated $3.86M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Transcend Capital Advisors's largest Q4 2021 buy was ITT: 21,295 shares worth $2.18M.
  • Transcend Capital Advisors added most to Microsoft in Q4 2021, an estimated $3.36M increase.
  • Transcend Capital Advisors's biggest Q4 2021 reduction was Intercontinental Exchange, cutting an estimated $3.86M.
  • Transcend Capital Advisors fully exited Quadratic Interest Rate Volatility and Inflation Hedge ETF in Q4 2021, selling an estimated $2.1M.
  • Transcend Capital Advisors's ten largest holdings make up 28% of its $1.13B portfolio in Q4 2021.
  • Transcend Capital Advisors opened 41 new positions and closed 40 in Q4 2021.
  • Transcend Capital Advisors's portfolio value rose 1.5% quarter-over-quarter to $1.13B.

Based on Transcend Capital Advisors's 13F filing for Q4 2021, filed 20 Jan 2022.